DNA banking

GENETIC2 trials

Sponsors

University Hospital, Lille, Taher Abu Hejleh

Conditions

CancerLung CancerMalignancy

Unknown Phase

A Clinico-biological Database of Lung Cancers

RecruitingNCT03387865

University Hospital, LilleLung Cancer

Start: 2019-03-13End: 2032-03-31Target: 500Updated: 2022-10-19

Microbiome in Lung Cancer and Other Malignancies

CompletedNCT03688347

Taher Abu HejlehCancer, Lung Cancer, Malignancy

Start: 2018-08-30End: 2022-05-09Updated: 2022-05-11

Related Papers

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

2021-07-1349 citations

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

Journal of Clinical Oncology2021-05-206 citations

Abstract B24: The microbiome in lung cancer under immunotherapy: Significant compositional differences associated with treatment response and AEs

Cancer Research2020-04-15